1-(1H-吡唑-1-基)-2-丙胺结构式
|
常用名 | 1-(1H-吡唑-1-基)-2-丙胺 | 英文名 | 1-(1H-Pyrazol-1-yl)propan-2-amine |
|---|---|---|---|---|
| CAS号 | 57939-04-5 | 分子量 | 125.17200 | |
| 密度 | N/A | 沸点 | N/A | |
| 分子式 | C6H11N3 | 熔点 | N/A | |
| MSDS | N/A | 闪点 | N/A |
| 中文名 | 1-(1H-吡唑-1-基)-2-丙胺 |
|---|---|
| 英文名 | 1-(1H-Pyrazol-1-yl)-2-propanamine |
| 英文别名 | 更多 |
| 分子式 | C6H11N3 |
|---|---|
| 分子量 | 125.17200 |
| 精确质量 | 125.09500 |
| PSA | 43.84000 |
| LogP | 0.93060 |
|
~%
1-(1H-吡唑-1-基)-2-丙胺 57939-04-5 |
| 文献：NEUROTHERAPEUTICS PHARMA, INC.; WANASKI, Stephen; COLLINS, Stephen; KINCAID, John Patent: WO2012/18635 A2, 2012 ; Location in patent: Page/Page column 111 ; WO 2012/018635 A2 |
|
~96%
1-(1H-吡唑-1-基)-2-丙胺 57939-04-5 |
| 文献：CONCERT PHARMACEUTICALS INC.; Tung, Roger Patent: US2014/128469 A1, 2014 ; Location in patent: Paragraph 0110; 0112 ; |
|
~%
1-(1H-吡唑-1-基)-2-丙胺 57939-04-5 |
| 文献：NEUROTHERAPEUTICS PHARMA, INC.; WANASKI, Stephen; COLLINS, Stephen; KINCAID, John Patent: WO2012/18635 A2, 2012 ; WO 2012/018635 A2 |
|
~%
1-(1H-吡唑-1-基)-2-丙胺 57939-04-5 |
| 文献：NEUROTHERAPEUTICS PHARMA, INC.; WANASKI, Stephen; COLLINS, Stephen; KINCAID, John Patent: WO2012/18635 A2, 2012 ; WO 2012/018635 A2 |
| 4-Methyl-3-nitro-benzoesaeure-methylester |
| 3-nitro-4-phenoxy-5-sulphamylbenzoic acid methyl ester |
| methyl 3-nitro-4-phenoxy-5-sulfamoylbenzoate |
| Methyl 3-nitro-p-toluate |
| Methyl 3-nitro-4-methylbenzoate |
| 3-nitro-4-phenoxy-5-sulfamoylbenzoic acid methyl ester |
| 4-Methyl-3-nitrobenzoic acid methyl ester |
